Cangshan Snow Chrysanthemum (Chrysanthemum morifolium 'Cangshan Snow')

Cangshan Snow Chrysanthemum (Chrysanthemum morifolium 'Cangshan Snow') is a cultivated chrysanthemum variety valued for its concentrated flavonoids, particularly quercetin glycosides and luteolin, which drive its antioxidant and anti-inflammatory properties. These phenolic compounds scavenge reactive oxygen species and modulate pro-inflammatory cytokine pathways, though human clinical evidence remains limited to traditional use and preliminary phytochemical studies.

Origin & History

Cangshan Snow Chrysanthemum (Chrysanthemum morifolium 'Cangshan Snow') is a specific cultivar variant native to regions like Cangshan in China, characterized by its distinctive snow-white flowers. The ingredient is derived from the flowering tops of this perennial herb in the Asteraceae family, typically processed through ethanol or solvent-based extraction methods on dried flowers.

Historical & Cultural Context

Cangshan Snow Chrysanthemum flowers have been used in traditional Chinese medicine as both a medicinal herb and popular beverage, valued historically for their phenolic content and potential health benefits. While C. morifolium has been studied for centuries in Chinese medicine systems, specific historical applications for this snow-white cultivar variant are not detailed in available sources.

Health Benefits

• Antioxidant support linked to phenolic compounds found in snow-white variants (traditional use evidence only)
• Potential anti-inflammatory effects suggested by flavonoid content including quercetin derivatives (preliminary evidence from phytochemical analysis)
• Traditional use for general wellness support in Chinese medicine systems (historical use only, no clinical trials)
• May support cellular health through compounds like chlorogenic acid and luteolin derivatives (based on chemical constituent analysis only)
• Traditional beverage use suggests digestive comfort benefits (historical use only, no clinical validation)

How It Works

The primary bioactives in Cangshan Snow Chrysanthemum—quercetin-3-O-glucoside and luteolin—inhibit nuclear factor-kappa B (NF-κB) signaling, suppressing downstream production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. Quercetin derivatives additionally chelate transition metal ions and directly scavenge superoxide and hydroxyl radicals, reducing oxidative stress measured via DPPH and ABTS assays. Chlorogenic acid present in the flower heads may further inhibit cyclooxygenase-2 (COX-2) enzyme activity, contributing to the anti-inflammatory profile.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specific to Cangshan Snow Chrysanthemum were identified in the available research. While general C. morifolium chemical constituent analyses exist in the literature, they focus on phytochemical identification rather than clinical outcomes, with no PMIDs provided for this specific cultivar.

Clinical Summary

No randomized controlled trials have been conducted specifically on the 'Cangshan Snow' cultivar in human subjects as of current literature. Evidence is derived from in vitro phytochemical analyses and comparative studies on Chrysanthemum morifolium varieties broadly, which have demonstrated antioxidant activity (IC50 values for DPPH scavenging ranging 0.1–0.5 mg/mL in flower extracts) and anti-inflammatory effects in cell-based models. Traditional Chinese medicine documents centuries of chrysanthemum use for eye health and mild fever, but these records are not cultivar-specific. The overall evidence grade remains preclinical and ethnobotanical, requiring controlled human trials before therapeutic claims can be substantiated.

Nutritional Profile

Cangshan Snow Chrysanthemum (Chrysanthemum morifolium 'Cangshan Snow') is primarily consumed as a herbal infusion; macronutrient content per dried flower (approximately 2-3g serving used for tea) is negligible — estimated <0.5g protein, <0.3g carbohydrates, <0.1g fat, and trace dietary fiber (~0.2-0.4g). Caloric contribution is minimal (<5 kcal per infusion). Micronutrient content includes trace potassium (estimated 20-40mg per dried 2g serving), small amounts of calcium (~5-10mg), and minimal magnesium and iron consistent with other Chrysanthemum morifolium cultivars. Key bioactive compounds include: flavonoids — primarily luteolin (reported 0.5-1.2mg/g dry weight in snow-type chrysanthemum variants), apigenin (~0.3-0.8mg/g dry weight), and quercetin derivatives (~0.2-0.6mg/g dry weight); chlorogenic acid and related caffeoylquinic acids (~1.0-3.5mg/g dry weight, consistent with C. morifolium species data); anthocyanin content is minimal given white-petal morphology, unlike pigmented cultivars. Volatile oils including camphor, borneol, and chrysanthenone are present in trace amounts (<0.5% of dry weight). Total polyphenol content is estimated at 15-35mg gallic acid equivalents per gram dry weight based on comparable snow-white C. morifolium cultivar data. Bioavailability note: flavonoid glycosides require intestinal hydrolysis before absorption; aqueous infusion extraction efficiency for chlorogenic acid and luteolin is moderate (~30-60% of total content); lipid-soluble terpenoid compounds have limited bioavailability in water-based preparations. Precise cultivar-specific analytical data for 'Cangshan Snow' is not independently published; values are interpolated from peer-reviewed studies on closely related C. morifolium white cultivars from Yunnan province.

Preparation & Dosage

No clinically studied dosage ranges are available for Cangshan Snow Chrysanthemum in any form (extract, powder, or standardized preparations). While general C. morifolium extracts show standardization to compounds like cynaroside (33% of isolate) and apigenin (5%), these are not linked to therapeutic dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea, Goji berry, Schisandra berry, White peony root, Honeysuckle flower

Safety & Interactions

Cangshan Snow Chrysanthemum is generally considered safe when consumed as a tea or food-grade preparation, consistent with the broad safety record of Chrysanthemum morifolium, though individuals with allergies to Asteraceae/Compositae family plants (including ragweed, daisies, and marigolds) face a risk of cross-reactive allergic reactions. High-dose supplemental extracts have not been formally evaluated for toxicity, and no established tolerable upper intake level exists. The quercetin content may theoretically interact with anticoagulants such as warfarin or antiplatelet drugs by inhibiting CYP3A4 and P-glycoprotein at concentrated doses, though this risk at typical tea consumption levels is considered low. Pregnant and breastfeeding individuals should avoid medicinal-strength preparations due to insufficient safety data, though culinary use is not specifically contraindicated.